Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas
Abstract Background Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consen...
Gespeichert in:
| Veröffentlicht in: | Neuro-oncology (Charlottesville, Va.) Va.), 2020-07, Vol.22 (7), p.928-935 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 935 |
|---|---|
| container_issue | 7 |
| container_start_page | 928 |
| container_title | Neuro-oncology (Charlottesville, Va.) |
| container_volume | 22 |
| creator | Bernhardt, Denise Wick, Wolfgang Weiss, Stephanie E Sahgal, Arjun Lo, Simon S Suh, John H Chang, Eric L Foote, Matthew Perry, James Meyer, Bernhard Vajkoczy, Peter Wen, Patrick Y Straube, Christoph Pigorsch, Steffi Wilkens, Jan J Combs, Stephanie E |
| description | Abstract
Background
Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGGs) during the coronavirus disease 2019 (COVID-19) pandemic.
Methods Sixteen
international experts in the treatment of HGG contributed to this consensus-based practice recommendation, including neuro-oncologists, neurosurgeons, radiation oncologists, and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in 2 pandemic scenarios, a scale-up phase and a crisis phase.
Conclusion
This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic. |
| doi_str_mv | 10.1093/neuonc/noaa113 |
| format | Article |
| fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7239150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/neuonc/noaa113</oup_id><sourcerecordid>10.1093/neuonc/noaa113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-1e23fd90cff523f5101140e7d3aa4563c8821f78f73956746e9dfef89de8392b3</originalsourceid><addsrcrecordid>eNqFkL1PwzAUxC0EoqWwMntlSOsX58NekFD5aKSKLlBGy43tNCixIycB9b8nkAqJiemd9O5-0h1C10DmQDhdWN07my-skxKAnqApxCENYpYkpz86DFgM6QRdtO07ISHECZyjCQ1pwhMCU6Sede9dMDBc5YoDrqWVha617bDqfWkL3O01Xm622X0AHDfSKl2XOf4suz2W2Li8b7Gz-G21wYWXSrc4yzI82HC2xUVVulq2l-jMyKrVV8c7Q6-PDy_LVbDePGXLu3WQR5R1AeiQGsVJbsxQwsRAACKiU0WljOKE5oyFYFJmUsrjJI0SzZXRhnGlGeXhjs7Q7cht-l2tVT608LISjS9r6Q_CyVL8_dhyLwr3IdKQcojJAJiPgNy7tvXa_GaBiO-9xbi3OO49BG7GgOub_7xf6IuC9Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Bernhardt, Denise ; Wick, Wolfgang ; Weiss, Stephanie E ; Sahgal, Arjun ; Lo, Simon S ; Suh, John H ; Chang, Eric L ; Foote, Matthew ; Perry, James ; Meyer, Bernhard ; Vajkoczy, Peter ; Wen, Patrick Y ; Straube, Christoph ; Pigorsch, Steffi ; Wilkens, Jan J ; Combs, Stephanie E</creator><creatorcontrib>Bernhardt, Denise ; Wick, Wolfgang ; Weiss, Stephanie E ; Sahgal, Arjun ; Lo, Simon S ; Suh, John H ; Chang, Eric L ; Foote, Matthew ; Perry, James ; Meyer, Bernhard ; Vajkoczy, Peter ; Wen, Patrick Y ; Straube, Christoph ; Pigorsch, Steffi ; Wilkens, Jan J ; Combs, Stephanie E</creatorcontrib><description>Abstract
Background
Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGGs) during the coronavirus disease 2019 (COVID-19) pandemic.
Methods Sixteen
international experts in the treatment of HGG contributed to this consensus-based practice recommendation, including neuro-oncologists, neurosurgeons, radiation oncologists, and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in 2 pandemic scenarios, a scale-up phase and a crisis phase.
Conclusion
This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noaa113</identifier><identifier>PMID: 32369601</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Editor's Choice ; Fast-Track</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2020-07, Vol.22 (7), p.928-935</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-1e23fd90cff523f5101140e7d3aa4563c8821f78f73956746e9dfef89de8392b3</citedby><cites>FETCH-LOGICAL-c438t-1e23fd90cff523f5101140e7d3aa4563c8821f78f73956746e9dfef89de8392b3</cites><orcidid>0000-0001-5231-9097</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239150/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239150/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1578,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Bernhardt, Denise</creatorcontrib><creatorcontrib>Wick, Wolfgang</creatorcontrib><creatorcontrib>Weiss, Stephanie E</creatorcontrib><creatorcontrib>Sahgal, Arjun</creatorcontrib><creatorcontrib>Lo, Simon S</creatorcontrib><creatorcontrib>Suh, John H</creatorcontrib><creatorcontrib>Chang, Eric L</creatorcontrib><creatorcontrib>Foote, Matthew</creatorcontrib><creatorcontrib>Perry, James</creatorcontrib><creatorcontrib>Meyer, Bernhard</creatorcontrib><creatorcontrib>Vajkoczy, Peter</creatorcontrib><creatorcontrib>Wen, Patrick Y</creatorcontrib><creatorcontrib>Straube, Christoph</creatorcontrib><creatorcontrib>Pigorsch, Steffi</creatorcontrib><creatorcontrib>Wilkens, Jan J</creatorcontrib><creatorcontrib>Combs, Stephanie E</creatorcontrib><title>Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas</title><title>Neuro-oncology (Charlottesville, Va.)</title><description>Abstract
Background
Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGGs) during the coronavirus disease 2019 (COVID-19) pandemic.
Methods Sixteen
international experts in the treatment of HGG contributed to this consensus-based practice recommendation, including neuro-oncologists, neurosurgeons, radiation oncologists, and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in 2 pandemic scenarios, a scale-up phase and a crisis phase.
Conclusion
This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic.</description><subject>Editor's Choice</subject><subject>Fast-Track</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkL1PwzAUxC0EoqWwMntlSOsX58NekFD5aKSKLlBGy43tNCixIycB9b8nkAqJiemd9O5-0h1C10DmQDhdWN07my-skxKAnqApxCENYpYkpz86DFgM6QRdtO07ISHECZyjCQ1pwhMCU6Sede9dMDBc5YoDrqWVha617bDqfWkL3O01Xm622X0AHDfSKl2XOf4suz2W2Li8b7Gz-G21wYWXSrc4yzI82HC2xUVVulq2l-jMyKrVV8c7Q6-PDy_LVbDePGXLu3WQR5R1AeiQGsVJbsxQwsRAACKiU0WljOKE5oyFYFJmUsrjJI0SzZXRhnGlGeXhjs7Q7cht-l2tVT608LISjS9r6Q_CyVL8_dhyLwr3IdKQcojJAJiPgNy7tvXa_GaBiO-9xbi3OO49BG7GgOub_7xf6IuC9Q</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Bernhardt, Denise</creator><creator>Wick, Wolfgang</creator><creator>Weiss, Stephanie E</creator><creator>Sahgal, Arjun</creator><creator>Lo, Simon S</creator><creator>Suh, John H</creator><creator>Chang, Eric L</creator><creator>Foote, Matthew</creator><creator>Perry, James</creator><creator>Meyer, Bernhard</creator><creator>Vajkoczy, Peter</creator><creator>Wen, Patrick Y</creator><creator>Straube, Christoph</creator><creator>Pigorsch, Steffi</creator><creator>Wilkens, Jan J</creator><creator>Combs, Stephanie E</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5231-9097</orcidid></search><sort><creationdate>20200701</creationdate><title>Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas</title><author>Bernhardt, Denise ; Wick, Wolfgang ; Weiss, Stephanie E ; Sahgal, Arjun ; Lo, Simon S ; Suh, John H ; Chang, Eric L ; Foote, Matthew ; Perry, James ; Meyer, Bernhard ; Vajkoczy, Peter ; Wen, Patrick Y ; Straube, Christoph ; Pigorsch, Steffi ; Wilkens, Jan J ; Combs, Stephanie E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-1e23fd90cff523f5101140e7d3aa4563c8821f78f73956746e9dfef89de8392b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Editor's Choice</topic><topic>Fast-Track</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bernhardt, Denise</creatorcontrib><creatorcontrib>Wick, Wolfgang</creatorcontrib><creatorcontrib>Weiss, Stephanie E</creatorcontrib><creatorcontrib>Sahgal, Arjun</creatorcontrib><creatorcontrib>Lo, Simon S</creatorcontrib><creatorcontrib>Suh, John H</creatorcontrib><creatorcontrib>Chang, Eric L</creatorcontrib><creatorcontrib>Foote, Matthew</creatorcontrib><creatorcontrib>Perry, James</creatorcontrib><creatorcontrib>Meyer, Bernhard</creatorcontrib><creatorcontrib>Vajkoczy, Peter</creatorcontrib><creatorcontrib>Wen, Patrick Y</creatorcontrib><creatorcontrib>Straube, Christoph</creatorcontrib><creatorcontrib>Pigorsch, Steffi</creatorcontrib><creatorcontrib>Wilkens, Jan J</creatorcontrib><creatorcontrib>Combs, Stephanie E</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernhardt, Denise</au><au>Wick, Wolfgang</au><au>Weiss, Stephanie E</au><au>Sahgal, Arjun</au><au>Lo, Simon S</au><au>Suh, John H</au><au>Chang, Eric L</au><au>Foote, Matthew</au><au>Perry, James</au><au>Meyer, Bernhard</au><au>Vajkoczy, Peter</au><au>Wen, Patrick Y</au><au>Straube, Christoph</au><au>Pigorsch, Steffi</au><au>Wilkens, Jan J</au><au>Combs, Stephanie E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2020-07-01</date><risdate>2020</risdate><volume>22</volume><issue>7</issue><spage>928</spage><epage>935</epage><pages>928-935</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>Abstract
Background
Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGGs) during the coronavirus disease 2019 (COVID-19) pandemic.
Methods Sixteen
international experts in the treatment of HGG contributed to this consensus-based practice recommendation, including neuro-oncologists, neurosurgeons, radiation oncologists, and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in 2 pandemic scenarios, a scale-up phase and a crisis phase.
Conclusion
This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>32369601</pmid><doi>10.1093/neuonc/noaa113</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5231-9097</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1522-8517 |
| ispartof | Neuro-oncology (Charlottesville, Va.), 2020-07, Vol.22 (7), p.928-935 |
| issn | 1522-8517 1523-5866 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7239150 |
| source | Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Editor's Choice Fast-Track |
| title | Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A19%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuro-oncology%20management%20during%20the%20COVID-19%20pandemic%20with%20a%20focus%20on%20WHO%20grades%20III%20and%20IV%20gliomas&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Bernhardt,%20Denise&rft.date=2020-07-01&rft.volume=22&rft.issue=7&rft.spage=928&rft.epage=935&rft.pages=928-935&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noaa113&rft_dat=%3Coup_pubme%3E10.1093/neuonc/noaa113%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32369601&rft_oup_id=10.1093/neuonc/noaa113&rfr_iscdi=true |